𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chemotherapy of primary malignant brain tumors in children

✍ Scribed by William R. Shapiro


Publisher
John Wiley and Sons
Year
1975
Tongue
English
Weight
703 KB
Volume
35
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Radiotherapy of primary malignant brain
✍ David A. Larson; William M. Wara πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 54 KB πŸ‘ 2 views

Radiotherapy is usually recommended for patients with a primary malignant brain tumor. The foundation for its use is grounded on the results of randomized trials for malignant gliomas which have demonstrated a relationship between survival and external beam radiation dose. Although similar trials ha

Radiosurgery for primary malignant brain
✍ Eben Alexander III; Jay S. Loeffler πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 64 KB πŸ‘ 2 views

Despite the ability of surgery, radiotherapy, and chemotherapy to prolong survival in patients with glioblastoma multiforme (GBM), most patients succumb to their disease, usually as a result of local tumor persistence or recurrence. Stereotactic radiosurgery (SRS) allows a substantial increase in to

Ototoxicity in children with malignant b
✍ Ilveskoski, Ismo; Saarinen, Ulla M.; Wiklund, Tom; PerkkiΓΆ, Mikko; Salmi, Toivo πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 481 KB πŸ‘ 1 views

Background. Adjuvant chemotherapy has improved the outcome of childhood malignant brain tumors in large randomized trials. With increasing survival rates, treatment toxicity has become a matter of concern. Radiation therapy and cisplatinum are known to be ototoxic. Methods. We evaluated the inciden

Chemotherapy of brain tumors
✍ Michael D. Prados; Carolyn Russo πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 52 KB πŸ‘ 1 views

For many years, chemotherapy has been utilized for the treatment of malignant brain tumors with minimal success. This particularly true with chemotherapy in adult malignant gliomas for which no new drug has been approved for use since the initial studies using nitrosoureas and procarbazine in the ea